Medical Oncology

Dr. Abha Gupta
Medical Oncologist, Princess Margaret/Sick Kids; Director, AYA Program

Dr. Gupta received her MD at the University of Toronto and completed her pediatrics residency at Yale New Haven Children’s Hospital (New Haven, CT). To complement her training, Dr. Gupta completed a one-year Fellowship in Adolescent and Young Adult Oncology with a focus on sarcoma. She is currently cross-appointed as a staff oncologist at The Hospital for Sick Children and Princess Margaret Cancer Centre.

Dr. Gupta is the Medical Director of the Adolescent and Young Adult (AYA) Program at The Princess Margaret, where she is working with a team of people to create the infrastructure to ensure consistent and high quality delivery of information and services to young people with cancer. Along with Pediatric Urologist Dr. Armando Lorenzo, Dr. Gupta is Co-Medical Director of the Fertility Preservation Program. The goal of this program is to ensure consistent and high quality delivery of information on fertility preservation to children and adolescents with cancer. Her research interests include AYA oncology and sarcoma. From 2006 to 2008, she received the Young Investigator Research Award in Adolescent & Young Adult Oncology from the American Association for Cancer Research.

Dr. Albi Razak
Medical Oncologist, Princess Margaret/MSH; Medical Oncology Lead, Sarcoma Site Group

Dr. Razak is the lead for Medical Oncology in The Princess Margaret/MSH’s Sarcoma Site Group. He is also the Interim Director representing Sinai Health Systems Oncology and Medical Genetics Programs. Dr. Razak completed his medical training in Ireland and his clinical training in Medical Oncology in the United Kingdom under the supervision of Dr. Hilary Calvert. He then completed a drug development fellowship at The Princess Margaret under the supervision of Dr. Lillian Siu.

Dr. Razak has a special interest in sarcoma and early drug development. His practice includes an active role in the Phase I Program at The Princess Margaret, developing and running drug clinical trials. He has been a recipient of the American Society of Clinical Oncology (ASCO) Merit Award, ASCO Young Investigator Award and was the inaugural recipient of the Mick Knighton-British Lung Foundation Mesothelioma Research Award, as well as the Canadian Sarcoma Cancer Foundation

Fellowship Award. Dr. Razak is appointed as a Clinician Investigator and Assistant Professor in the Department of Medicine, University of Toronto.

Dr. Geoff Watson
Medical Oncologist, Mount Sinai Hospital

Dr. Geoffrey Watson is a Staff Medical Oncologist at Mount Sinai Hospital and an Assistant Professor of Medicine at the University of Toronto. He completed his basic and specialized training in medical oncology in Dublin, Ireland.

Dr. Watson joined the Drug Development and Sarcoma Programs at the Princess Margaret Cancer Centre as a clinical research fellow in 2019. During this time he served as the Chief Fellow of the Division of Medical Oncology and Hematology, and was awarded with a Hold’em for Life Oncology Clinician Scientist Award in 2019, an ASCO Merit Award in 2020 and 2021 as well as the Novartis Oncology Young Canadian Investigator Award in 2020 and 2021.

Dr. Watson’s clinical focus is on the treatment of sarcoma and breast cancer. His academic interest is in patient reported outcomes and quality of life, and he also has an interest in teaching and education, particularly the evolving role of virtual education.

Dr. Abdulazeez Salawu
Medical Oncologist, Mount Sinai Hospital

Dr Salawu trained in Medical Oncology at the Weston Park Cancer Centre, Sheffield, United Kingdom and completed a fellowship in sarcoma and early phase drug development and at Princess Margaret Cancer Centre, Toronto.  Prior to this, he obtained Masters’ and Doctoral degrees from the University of Sheffield, United Kingdom, during which he studied structural and functional genomics of soft tissue sarcoma, disease models and biomarker development.

He is the recipient of a Novartis Oncology Young Canadian Investigator Award and the American Society of Clinical Oncology (ASCO) Merit and Young Investigator Awards.   His current research interests are in translational oncology and biomarker development, clinical trials and ultra-rare sarcomas.

He is currently appointed as Assistant Professor of Medicine, University of Toronto and Staff Medical Oncologist at Mount Sinai Hospital and Princess Margaret Cancer Centre, Toronto.

   Back to Our Team